(MedicalNewsToday) Study leader Dr. Giovanni Marsicano, of the University of Bordeaux in France, and team believe their findings - published in the journal Nature - may lead to the development of new therapeutics that target cannabinoid receptors, without the side effect of memory loss. In the new study, Dr. Marsicano and team further explored the relationship between cannabinoids and memory loss.
CB1 cannabinoid receptors in mitochondria regulate memory processes
